drugset
drugset / Trial / NCT03492840

Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease

NCT03492840 ↗

Phase 2 Completed 12 enrolled Raziel Therapeutics Ltd. University of Arizona · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is an open label, 2 cohort, clinical trial in women with lipedema with substantial fat above the knee and men with Dercum's disease. Each cohort will have 6 subjects who will receive RZL-012.

Timeline

Start
2018-06-28
Primary completion
2019-05-02
Completion
2019-05-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator UTENPANIUM Small molecule 10 mg Other
Comparator UTENPANIUM Small molecule 15 mg Other
Comparator UTENPANIUM Small molecule 20 mg Other
Comparator UTENPANIUM Small molecule 60 mg Other
Comparator UTENPANIUM Small molecule 80 mg Other

Indications

Lipedema adiposis dolorosa